Transforming growth factor-β1 polymorphisms and graftversus- host disease risk: A meta-analysis

Oncotarget

Volumn 7, Issue 3, 2016, Pages 2455-2461

  Zhang, Lin ^a   Mao, Lihong ^a   Xu, Junxiu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Genetic; Graft versus host disease; Meta analysis; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; RISK ASSESSMENT; TGF BETA1 GENE; YOUNG ADULT; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PROGNOSIS; RISK FACTOR;

GENETIC PREDISPOSITION TO DISEASE; GRAFT VS HOST DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84962265501     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6289     Document Type: Article

References (20)

1. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007 Oct 11;357:1472-5.
2. Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis. 2007 Sep 4;2:35.
3. Ogawa S, Matsubara A, Onizuka M, Kashiwase K, Sanada M, Kato M, Nannya Y, Akatsuka Y, Satake M, Takita J, Chiba S, Saji H, Maruya E, Inoko H, Morishima Y, Kodera Y, Takehiko S; Japan Marrow Donation Program (JMDP). Exploration of the genetic basis of GVHD by genetic association studies. Biol Blood Marrow Transplant. 2009 Jan;15:39-41.
4. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol. 2002 Feb;118:211-5.
5. Zheng SG, Wang JH, Koss MN, Quismorio F Jr, Gray JD, Horwitz DA. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versus-host disease with a lupus-like syndrome. J Immunol. 2004 Feb 1;172:1531-9.
6. Li Q, Zhai Z, Xu X, Shen Y, Zhang A, Sun Z, Liu H, Geng L, Wang Y. Decrease of CD4(+)CD25(+) regulatory T cells and TGF-beta at early immune reconstitution is associated to the onset and severity of graft-versus-host disease following allogeneic haematogenesis stem cell transplantation. Leuk Res. 2010 Sep;34:1158-68.
7. Holweg CT, Baan CC, Balk AH, Niesters HG, Maat AP, Mulder PM, Weimar W. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation. 2001 May 27;71:1463-7.
8. Laguila Visentainer JE, Lieber SR, Lopes Persoli LB, Dutra Marques SB, Vigorito AC, Penteado Aranha FJ, de Brito Eid KA, Oliveira GB, Martins Miranda EC, Bragotto L, de Souza CA. Relationship between cytokine gene polymorphisms and graft-versus-host disease after allogeneic stem cell transplantation in a Brazilian population. Cytokine. 2005 Nov 3;32:171-7.
9. Noori-Daloii MR, Rashidi-Nezhad A, Izadi P, Hossein-Nezhad A, Sobhani M, Derakhshandeh-Peykar P, Alimoghaddam K, Ghavamzadeh A. Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population. Ann Transplant. 2007;12:5-10.
10. Shah R, Selby ST, Yokley B, Slack RS, Hurley CK, Posch PE. TNF, LTA and TGFB1 genotype distributions among acute graft-vs-host disease subsets after HLA-matched unrelated hematopoietic stem cell transplantation: a pilot study. Tissue Antigens. 2009 Jul;74:50-6.
11. Berro M, Mayor NP, Maldonado-Torres H, Cooke L, Kusminsky G, Marsh SG, Madrigal JA, Shaw BE. Berro M1, Mayor NP, Maldonado-Torres H, Cooke L, Kusminsky G, Marsh SG, Madrigal JA, Shaw BE. Association of functional polymorphisms of the transforming growth factor B1 gene with survival and graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation. Haematologica. 2010 Feb;95:276-83.
12. Karimi MH, Daneshmandi S, Pourfathollah AA, Geramizadeh B, Ramzi M, Yaghobi R, Ebadi P. The IFN-gamma allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplant. Exp Clin Transplant. 2010 Jun;8:125-9.
13. Rashidi-Nezhad A, Azimi C, Alimoghaddam K, Ghavamzadeh A, Hossein-Nezhad A, Izadi P, Sobhani M, Noori-Daloii AR, Noori-Daloii MR. TGF-Beta codon 25 polymorphism and the risk of graft-versus-host disease after allogenic hematopoietic stem cell transplantation. Iran J Allergy Asthma Immunol. 2010 Mar;9:1-6.
14. Xiao H, Cao W, Lai X, Luo Y, Shi J, Tan Y, He J, Xie W, Meng X, Zheng W, Zheng G, Han X, Jin L, Zhang L, Wang Y, Yu X, Cai Z, Lin M, Ye X, Huang H. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a chinese population. Biol Blood Marrow Transplant. 2011 Apr;17:542-9.
15. Kim D, Won HH, Su S, Cheng L, Xu W, Hamad N, Uhm J, Gupta V, Kuruvilla J, Messner HA, Lipton JH. Risk stratification of organ-specific GVHD can be improved by single-nucleotide polymorphism-based risk models. Bone Marrow Transplant. 2014 May;49:649-56.
16. Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol. 2002 Jan;2:46-53.
17. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000 May 1;95:2754-9.
18. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999 Jan;8:93-7.
19. Pooja S, Francis A, Rajender S, Tamang R, Rajkumar R, Saini KS, Megu K, Goel MM, Surekha D, Rao DR, Rao L, Ramachandra L, Kumar S, Kumar S, Vishnupriya S, Satyamoorthy K, Negi MP, Thangaraj K, Konwar R. Strong impact of TGF-β1 gene polymorphisms on breast cancer risk in Indian women: a case-control and population-based study. PLoS One. 2013;8:e75979
20. GA Wells, B Shea, D O'Connell, J Peterson, V Welch, M Losos, P Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.